871 The Use of Automated Image-cytometry for Improved Non-invasive Bladder Cancer Detection by Multiprobe FISH Assay

2012 ◽  
Vol 48 ◽  
pp. S210
Author(s):  
G. Pajor ◽  
D. Alpar ◽  
B. Knief ◽  
N. Sule ◽  
B. Kajtar ◽  
...  
2020 ◽  
Vol 22 ◽  
pp. e00189
Author(s):  
Hideki Furuya ◽  
Lindlelyn Tabula ◽  
Riko Lee ◽  
Paul Kralovec ◽  
Martin Ramsden ◽  
...  

2018 ◽  
Vol 17 (2) ◽  
pp. e1425
Author(s):  
D. Ward ◽  
I. Russo ◽  
Y. Ju ◽  
N. Gordon ◽  
M. Zeegers ◽  
...  

2017 ◽  
Vol 143 (9) ◽  
pp. 1757-1769 ◽  
Author(s):  
Karsten Salomo ◽  
Doreen Huebner ◽  
Manja U. Boehme ◽  
Alexander Herr ◽  
Werner Brabetz ◽  
...  

1993 ◽  
Vol 79 (3) ◽  
pp. 284-284
Author(s):  
Daniel Seigneurin ◽  
Jean-Jacques Rambeaud ◽  
Josette Louis

2015 ◽  
Vol 26 (2) ◽  
pp. S47-S48
Author(s):  
Yuh-Shyan Tsai ◽  
Yeong-Chin Jou ◽  
Yen-Ping Tsai ◽  
Bin-Da Liu ◽  
Hung-In Lin ◽  
...  

Author(s):  
Richard P. Meijer ◽  
Alexandre R. Zlotta ◽  
Bas W.G. van Rhijn

High-grade non-muscle-invasive bladder cancer (HG-NMIBC) represents the most aggressive spectrum of this non-invasive cancer. This collective term includes all high-grade NMI urothelial carcinoma (UC), such as those without invasion (pTa), those with lamina propria invasion (pT1), and those that are only/have concomitant carcinoma in situ (CIS; pTis). These cancers have a high risk for intravesical recurrence (around 46–78% at five years) and progression (between 6–45% at five years) to muscle-invasive bladder cancer (MIBC). As with all UC, their presentation can be with visible haematuria or irritative lower urinary tract symptoms. The latter are common in patients with CIS. CIS may be detected in isolation (so-called primary CIS) or with a coexisting UC elsewhere (termed concomitant CIS). While urinary cytology has a moderate sensitivity and high specificity (>90%) for the detection of HG-NMIBC, cystoscopy is the most important diagnostic tool.


Sign in / Sign up

Export Citation Format

Share Document